These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 25043452)

  • 41. Trachoma: transmission, infection, and control.
    Gambhir M; Basáñez MG; Turner F; Kumaresan J; Grassly NC
    Lancet Infect Dis; 2007 Jun; 7(6):420-7. PubMed ID: 17521595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The SAFE strategy for the elimination of trachoma by 2020: will it work?
    Bailey R; Lietman T
    Bull World Health Organ; 2001; 79(3):233-6. PubMed ID: 11285668
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of trichiasis in a cohort of women with and without scarring.
    Muñoz B; Bobo L; Mkocha H; Lynch M; Hsieh YH; West S
    Int J Epidemiol; 1999 Dec; 28(6):1167-71. PubMed ID: 10661664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modeling the "F" in "SAFE": The dynamic game of facial cleanliness in trachoma prevention.
    Barazanji M; Ngo JD; Powe JA; Schneider KP; Rychtář J; Taylor D
    PLoS One; 2023; 18(6):e0287464. PubMed ID: 37352249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Who steps up efforts against trachoma.
    Kmietowicz Z
    BMJ; 1996 Dec; 313(7070):1428. PubMed ID: 8973227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification.
    Yang JL; Hong KC; Schachter J; Moncada J; Lekew T; House JI; Zhou Z; Neuwelt MD; Rutar T; Halfpenny C; Shah N; Whitcher JP; Lietman TM
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):90-4. PubMed ID: 18689701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for trichiasis in women in Kongwa, Tanzania: a case-control study.
    Turner VM; West SK; Muñoz B; Katala SJ; Taylor HR; Halsey N; Mmbaga BB
    Int J Epidemiol; 1993 Apr; 22(2):341-7. PubMed ID: 8505194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection.
    Atik B; Thanh TT; Luong VQ; Lagree S; Dean D
    JAMA; 2006 Sep; 296(12):1488-97. PubMed ID: 17003397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Photographic grading to evaluate facial cleanliness and trachoma among children in Amhara region, Ethiopia.
    Caleon RL; Admassu F; Aragie S; Hailu D; Dagnew A; Zeru T; Wittberg DM; Thompson IJB; Abdu S; Beyecha S; Birhanu T; Getachew H; Getnet B; Kabtu E; Shibiru M; Tekew S; Wondimteka B; Lietman TM; Nash SD; Freeman MC; Keenan JD
    PLoS Negl Trop Dis; 2024 Jul; 18(7):e0012257. PubMed ID: 38991011
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Achieving trachoma control in Ghana after implementing the SAFE strategy.
    Yayemain D; King JD; Debrah O; Emerson PM; Aboe A; Ahorsu F; Wanye S; Ansah MO; Gyapong JO; Hagan M
    Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):993-1000. PubMed ID: 19286239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. OmpA genotypic evidence for persistent ocular Chlamydia trachomatis infection in Tanzanian village women.
    Smith A; Muñoz B; Hsieh YH; Bobo L; Mkocha H; West S
    Ophthalmic Epidemiol; 2001 Jul; 8(2-3):127-35. PubMed ID: 11471082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors for recurrence of postoperative trichiasis: implications for trachoma blindness prevention.
    Zhang H; Kandel RP; Sharma B; Dean D
    Arch Ophthalmol; 2004 Apr; 122(4):511-6. PubMed ID: 15078668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Longitudinal evaluation of three azithromycin distribution strategies for treatment of trachoma in a sub-Saharan African country, Mali.
    Schémann JF; Guinot C; Traore L; Zefack G; Dembele M; Diallo I; Traore A; Vinard P; Malvy D
    Acta Trop; 2007 Jan; 101(1):40-53. PubMed ID: 17239332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The global burden of trachoma: a review.
    Burton MJ; Mabey DC
    PLoS Negl Trop Dis; 2009 Oct; 3(10):e460. PubMed ID: 19859534
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduction of trachoma in a sub-Saharan village in absence of a disease control programme.
    Dolin PJ; Faal H; Johnson GJ; Minassian D; Sowa S; Day S; Ajewole J; Mohamed AA; Foster A
    Lancet; 1997 May; 349(9064):1511-2. PubMed ID: 9167460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elimination of blinding trachoma.
    Schachter J; Dawson CR
    Curr Opin Infect Dis; 2002 Oct; 15(5):491-5. PubMed ID: 12686881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for postsurgical trichiasis recurrence in a trachoma-endemic area.
    West ES; Mkocha H; Munoz B; Mabey D; Foster A; Bailey R; West SK
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):447-53. PubMed ID: 15671268
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Facial cleanliness and risk of trachoma in families.
    West SK; Congdon N; Katala S; Mele L
    Arch Ophthalmol; 1991 Jun; 109(6):855-7. PubMed ID: 2043075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibiotics for trachoma.
    Evans JR; Solomon AW
    Cochrane Database Syst Rev; 2011 Mar; (3):CD001860. PubMed ID: 21412875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Will the SAFE strategy be sufficient to eliminate trachoma by 2020? Puzzlements and possible solutions.
    Lavett DK; Lansingh VC; Carter MJ; Eckert KA; Silva JC
    ScientificWorldJournal; 2013; 2013():648106. PubMed ID: 23766701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.